http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4888414-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate 1987-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1989-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbf77a455714711c4c3d7e5740bc4230
publicationDate 1989-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4888414-A
titleOfInvention Insulin-binding peptides and uses thereof
abstract The present invention concerns a novel class of peptides which specifically bind insulin. The diverse uses of these peptides relate to insulin, insulin action and the cellular receptor for insulin. The most preferred peptide of the invention is the hexapeptide-NH 2 -cys-val-glu-glu-ala-ser-COOH which has marked affinity for the insulin B-chain. n Antibodies having specific binding affinity for peptides of the invention have identified and forseen uses. Such antibodies specifically directed toward a preferred peptide of the invention comprising cys-val-glu-glu-ala-ser represent a further preferred aspect of antibody-related aspects of the present invention. n In one significant aspect, the present invention involves a method for determining insulin levels in a biological fluid. A further aspect of the present invention involves a process for measuring insulin receptor sites involving the binding of antibodies to cells or cell fractions. n The present invention further comprises a method for decreasing the amount of biologically active insulin present in a biological fluid such as the blood of an animal. This method involves parenterally administering an amount of peptide of the invention in free or carrier-conjugated form.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9203152-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5872220-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6893816-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006084106-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114675019-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114675019-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10352920-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5843767-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016179568-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11052133-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6025465-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7125674-B2
priorityDate 1987-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4581165-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3907765-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4569792-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4569791-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10444661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235765441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88617324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235765491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88617317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235765489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399014
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129216168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19836240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127392137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19836239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129518404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235765450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235

Total number of triples: 63.